BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majo S, Courtois S, Souleyreau W, Bikfalvi A, Auguste P. Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior. Front Oncol 2020;10:625. [PMID: 32411604 DOI: 10.3389/fonc.2020.00625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Onyeisi JOS, Lopes CC, Götte M. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer. Biomolecules 2021;11:503. [PMID: 33810567 DOI: 10.3390/biom11040503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Abbott A, Bond K, Chiba T, Sims-Lucas S, Oxburgh L, Coburn JM. Development of a mechanically matched silk scaffolded 3D clear cell renal cell carcinoma model. Mater Sci Eng C Mater Biol Appl 2021;126:112141. [PMID: 34082952 DOI: 10.1016/j.msec.2021.112141] [Reference Citation Analysis]
3 Huang Y, Zeng H, Chen L, Luo Y, Ma X, Zhao Y. Exploration of an Integrative Prognostic Model of Radiogenomics Features With Underlying Gene Expression Patterns in Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:640881. [PMID: 33763374 DOI: 10.3389/fonc.2021.640881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ren X, Chen X, Ji Y, Li L, Li Y, Qin C, Fang K. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome. Aging (Albany NY) 2020;12:25878-94. [PMID: 33232285 DOI: 10.18632/aging.202153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ahluwalia P, Ahluwalia M, Mondal AK, Sahajpal N, Kota V, Rojiani MV, Rojiani AM, Kolhe R. Prognostic and therapeutic implications of extracellular matrix associated gene signature in renal clear cell carcinoma. Sci Rep 2021;11:7561. [PMID: 33828127 DOI: 10.1038/s41598-021-86888-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Keller-Pinter A, Gyulai-Nagy S, Becsky D, Dux L, Rovo L. Syndecan-4 in Tumor Cell Motility. Cancers (Basel) 2021;13:3322. [PMID: 34282767 DOI: 10.3390/cancers13133322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]